Fibulin-2: A Novel Biomarker for Differentiating Grade II from Grade I Meningiomas

There is an unmet need for the identification of biomarkers to aid in the diagnosis, clinical management, prognosis and follow-up of meningiomas. There is currently no consensus on the optimum management of WHO grade II meningiomas. In this study, we identified the calcium binding extracellular matr...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Int J Mol Sci
Prif Awduron: Sofela, Agbolahan A., Hilton, David A., Ammoun, Sylwia, Baiz, Daniele, Adams, Claire L., Ercolano, Emanuela, Jenkinson, Michael D., Kurian, Kathreena M., Teo, Mario, Whitfield, Peter C., Sahm, Felix, Hanemann, C. Oliver
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: MDPI 2021
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7827565/
https://ncbi.nlm.nih.gov/pubmed/33429944
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms22020560
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg